Skip to main content

Table 3 Patient- and FP-related predictors of antibiotic prescribing (as per unadjusted analysis and binary logistic regression model)

From: Impact of educational training and C-reactive protein point-of-care testing on antibiotic prescribing in rural and urban family physician practices in Latvia: a randomised controlled intervention study

Characteristics

Antibiotic prescriptions

n (%)

Crude OR (95% CI)

P

Adjusted ORa (95% CI)

P

Patient-related factors

 Age (years)

  0–4

294 (32.1)

1

 

1

 

  5–9

187 (28.2)

0.83 (0.67–1.04)

0.10

0.81 (0.65–1.02)

0.07

  10–14

71 (23.2)

0.64 (0.47–0.86)

0.003

0.62 (0.46–0.85)

0.002

  15–17

42 (33.9)

1.08 (0.73–1.61)

0.70

1.10 (0.73–1.66)

0.64

 Sex

  Boys

295 (28.6)

1

 

1

 

  Girls

309 (31.3)

1.12 (0.93–1.36)

0.23

1.16 (0.96–1.41)

0.14

 Duration of symptoms (days)

  1

22 (22.2)

1

 

1

 

  2

152 (25.0)

1.17 (0.70–1.94)

0.55

1.08 (0.64–1.81)

0.78

  3

223 (33.1)

1.73 (1.05–2.85)

0.03

1.53 (0.91–2.57)

0.11

  4

137 (32.6)

1.69 (1.01–2.84)

0.045

1.57 (0.92–2.68)

0.10

  5

73 (30.5)

1.54 (0.89–2.66)

0.12

1.50 (0.84–2.65)

0.17

FP-related factors

 Age (years)

  30–40

89 (25.2)

1

 

1

 

  41–50

172 (36.1)

1.67 (1.23–2.27)

0.001

1.76 (1.24–2.51)

0.002

  51–60

167 (25.7)

1.02 (0.76–1.38)

0.88

0.96 (0.69–1.32)

0.79

  61+

179 (32.1)

1.40 (1.04–1.89)

0.03

1.12 (0.80–1.57)

0.52

 Sex

  Male

15 (32.6)

1

 

1

 

  Female

529 (29.7)

0.87 (0.47–1.63)

0.67

0.92 (0.47–1.80)

0.81

 Work experience

   < 5 years

48 (25.7)

1

 

1

 

  6–10 years

15 (14.6)

0.49 (0.26–0.94)

0.03

0.70 (0.35–1.41)

0.32

  11–20 years

106 (31.4)

1.32 (0.89–1.98)

0.17

1.52 (0.96–2.41)

0.08

  21+ years

438 (31.0)

1.30 (0.92–1.84)

0.13

1.28 (0.87–1.86)

0.21

 Location of practice

  Rural areas

246 (33.0)

1.28 (1.04–1.59)

0.02

1.42 (1.10–1.84)

0.01

  Regional cities

119 (28.3)

1.03 (0.80–1.34)

0.82

1.23 (0.92–1.65)

0.16

  Capital of Latvia

242 (27.7)

1

 

1

 

 Number of paediatric patients in practice

   < 500

266 (25.6)

1

 

1

 

  501–1000

267 (34.7)

1.54 (1.26–1.89)

< 0.001

1.68 (1.33–2.11)

< 0.001

  1001+

74 (31.9)

1.36 (1.26–1.89)

0.05

1.59 (1.09–2.34)

0.02

 Study group

  Intervention

320 (27.8)

0.80 (0.66–0.97)

0.02

0.83 (0.67–1.03)

0.09

  Control

287 (32.4)

1

 

1

 
  1. aAdjusted OR: adjusted odds ratio – adjusted for all independent variables in the table, except the age of FP due to the collinearity with the duration of the career of FP (for age of FP variable adjustment has been carried out for all the variables except the duration of career)